Insight

Scotland is at the forefront of industrial biotechnology and engineering biology, sectors that have become crucial for sustainable development and economic growth. With a legacy of scientific innovation, Scotland is harnessing the power of biotechnology to create a sustainable future. The global market for biosynthetic products has reached $100 billion[1], with biomanufacturing set to disrupt various industries, including pharmaceuticals, food, and chemicals‚Äã‚Äã.

The Scottish Vision for Industrial Biotechnology

Industrial biotechnology is a vanguard of the rapidly expanding Scottish life sciences sector. The Scottish industrial biotechnology sector is exceeding its growth forecasts and is poised to meet the turnover goal of £1.2 billion by 2025[2], as stipulated in the National Plan for Industrial Biotechnology (2022). This updated plan further aims for the sector to encompass 220 enterprises, contributing to the support of 4,000 employment opportunities.

Scotland boasts over 130 companies that have industrial biotechnology at the core of their business strategy[3]. Among these, global players with bases in Scotland, such as GSK and Thermo Fisher, are prominent, demonstrating Scotland’s capacity to attract and nurture businesses with a global impact. The indigenous Scottish industrial biotechnology supply chain features a range of exciting, rapidly growing SMEs. For example, Celtic Renewables and MiAlgae are two manufacturing companies that have reached pilot plant scales. Other established players in the economy include Ingenza, an international leader in microbial strain engineering; Roslin CT, a mammalian cell developer and manufacturer; and a large number of companies across chemicals, biomaterials, and food market spaces.

Overall, Scotland’s industrial biotechnology sector, contributing significantly to its economy, is on track to exceed its growth expectations, with companies achieving combined revenues nearing £750 million. This rapid expansion from 24 companies in 2012 to 130 by 2021 demonstrates the sector’s dynamic growth and its crucial role in Scotland’s transition to a bioeconomy[4]‚Äã‚Äã.

The Need for Strategic Intervention

The shift towards sustainable manufacturing, driven by global demand for environmentally friendly and carbon-neutral products, presents both opportunities and challenges. Achieving commercial-scale, cost-effective biomanufacturing is pivotal for meeting the sustainability goals set by international agreements and national policies. However, the high costs associated with precision fermentation and biomanufacturing at this scale still need to be overcome ‚Äã‚Äã.

One way of doing this is to foster a supportive ecosystem that includes scaleup facilities and biofoundries that are available to companies that, otherwise, could not afford the capital investment required, to demonstrate and accelerate their product and process development. Biofoundries – large-scale biomanufacturing facilities which are considered to be key to reducing production costs and achieving commercial viability for non-pharma bioproducts – offer the promise of significantly lowering the cost of biologically manufactured goods, making them competitive with traditional manufacturing methods and unlocking a potential $200 billion market by 2040[5]‚Äã‚Äã.

Collaborative Innovation for Global Impact

The Industrial Biotechnology Innovation Centre (IBioIC) plays a pivotal role in fostering growth, by linking industry with academic expertise and facilitating commercialization of biotech solutions. The collaborative environment fostered by IBioIC is a key factor in the sector’s success, enabling Scotland to emerge as a major player in industrial biotechnology on the global stage‚Äã‚Äã‚Äã‚Äã. The recent data shows that IBioIC has substantially encouraged the growth of the Scottish industrial biotechnology sector by supporting more than 260 companies that together attracted more that £35 million of additional funding for R&D[6].

Scotland’s strategic focus on industrial biotechnology not only aligns with its sustainability goals but also positions it as a leader in the global shift towards greener manufacturing processes. Through strategic partnerships, innovative companies, and supportive infrastructure like IBioIC, Scotland is showcasing the potential of biotechnology to drive economic growth while addressing environmental challenges.

Final remarks

In conclusion, Scotland’s industrial biotechnology sector showcases immense potential, high levels of ambition, and excellence in innovation. The journey towards sustainable manufacturing and economic prosperity further hinges on presenting compelling business cases and effectively communicating value to attract investment and stimulate business growth. Companies within this vibrant sector must articulate their contributions not only to the economy but also to a sustainable future. This is where Optimat, a strategy consultancy, steps in‚Äîoffering expertise in market analysis, strategy development, and value communication. Optimat can play a pivotal role in unlocking the potential of biotechnology firms, guiding them through the intricacies of business planning and investment attraction, thus bolstering Scotland’s position as a leader in the global bioeconomy. Get in touch with us to discuss your support needs.